Spero Therapeutics Inc (SPRO) — Capital Reinvestment Ratio

Latest as of December 2022: 0.00x

Spero Therapeutics Inc (SPRO) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($44.48 Million) in capital expenditures ($129.00K). See free cash flow generation of Spero Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$44.48 Million

USD

Capital Expenditures

$129.00K

USD

Data as of

Dec 2022

Most recent filing

Annual Capital Reinvestment Ratio for Spero Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Spero Therapeutics Inc from None to None. For live market cap and broader valuation context, see SPRO company net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow